155 related articles for article (PubMed ID: 36267893)
1. Family case studies: absence of
Sobala R; Brooks K; Davison J; Lumb J; De Soyza A
ERJ Open Res; 2022 Oct; 8(4):. PubMed ID: 36267893
[No Abstract] [Full Text] [Related]
2. Virulence adaptations of
Woo TE; Duong J; Jervis NM; Rabin HR; Parkins MD; Storey DG
Microbiology (Reading); 2016 Dec; 162(12):2126-2135. PubMed ID: 27902425
[No Abstract] [Full Text] [Related]
3. Meta-analysis of efficacy and safety of inhaled ciprofloxacin in non-cystic fibrosis bronchiectasis patients.
Wang S; Zhang A; Yao X
Intern Med J; 2021 Sep; 51(9):1505-1512. PubMed ID: 33469994
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant
Ding F; Han L; Xue Y; Yang IT; Fan X; Tang R; Zhang C; Zhu M; Tian X; Shao P; Zhang M
Front Cell Infect Microbiol; 2022; 12():934439. PubMed ID: 35967851
[TBL] [Abstract][Full Text] [Related]
5. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis.
Wilson R; Aksamit T; Aliberti S; De Soyza A; Elborn JS; Goeminne P; Hill AT; Menendez R; Polverino E
Respir Med; 2016 Aug; 117():179-89. PubMed ID: 27492530
[TBL] [Abstract][Full Text] [Related]
6. Eradication of
Blanco-Aparicio M; Saleta Canosa JL; Valiño López P; Martín Egaña MT; Vidal García I; Montero Martínez C
Chron Respir Dis; 2019; 16():1479973119872513. PubMed ID: 31480862
[TBL] [Abstract][Full Text] [Related]
7. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis.
Goeminne PC; Nawrot TS; Ruttens D; Seys S; Dupont LJ
Respir Med; 2014 Feb; 108(2):287-96. PubMed ID: 24445062
[TBL] [Abstract][Full Text] [Related]
8. Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with
Tanriverdi E; Yildirim BZ; Gul S; Chousein EGU; Turan D; Çınarka H; Özgül MA; Cetinkaya E
J Aerosol Med Pulm Drug Deliv; 2021 Sep; 34(5):274-279. PubMed ID: 33351705
[No Abstract] [Full Text] [Related]
9. Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study.
Choate R; Aksamit TR; Mannino D; Addrizzo-Harris D; Barker A; Basavaraj A; Daley CL; Daniels MLA; Eden E; DiMango A; Fennelly K; Griffith DE; Johnson MM; Knowles MR; McShane PJ; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Salathe MA; Schmid A; Thomashow B; Tino G; Winthrop KL; Stone G
Respir Med; 2021 Feb; 177():106285. PubMed ID: 33401148
[TBL] [Abstract][Full Text] [Related]
10. Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
Tejada S; Campogiani L; Solé-Lleonart C; Gómez A; Gallego M; Vendrell M; Soriano JB; Rello J
Eur J Intern Med; 2021 Aug; 90():77-88. PubMed ID: 33947626
[TBL] [Abstract][Full Text] [Related]
11. Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis.
Diel R; Ewig S; Blaas S; Jacob C; Juelich F; Korfmann G; Sohrab S; Sutharsan S; Rademacher J
Respir Med; 2019 May; 151():121-127. PubMed ID: 31047108
[TBL] [Abstract][Full Text] [Related]
12. Hot topics and current controversies in non-cystic fibrosis bronchiectasis.
Severiche-Bueno D; Gamboa E; Reyes LF; Chotirmall SH
Breathe (Sheff); 2019 Dec; 15(4):286-295. PubMed ID: 31803263
[TBL] [Abstract][Full Text] [Related]
13. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.
Tay GT; Reid DW; Bell SC
Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593
[TBL] [Abstract][Full Text] [Related]
14. Using Cystic Fibrosis Therapies for Non-Cystic Fibrosis Bronchiectasis.
ElMaraachli W; Conrad DJ; Wang AC
Clin Chest Med; 2016 Mar; 37(1):139-46. PubMed ID: 26857775
[TBL] [Abstract][Full Text] [Related]
15. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
Paredes Aller S; Quittner AL; Salathe MA; Schmid A
Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
[TBL] [Abstract][Full Text] [Related]
16. Does the effect of comprehensive respiratory physiotherapy home-program differ in children with cystic fibrosis and non-cystic fibrosis bronchiectasis?
Gurses HN; Ucgun H; Zeren M; Denizoglu Kulli H; Cakır E
Eur J Pediatr; 2022 Aug; 181(8):2961-2970. PubMed ID: 35595860
[TBL] [Abstract][Full Text] [Related]
17. Effect of macrolide on lung function and computed tomography (CT) score in non-cystic fibrosis bronchiectasis.
Goeminne PC; Soens J; Scheers H; De Wever W; Dupont L
Acta Clin Belg; 2012; 67(5):338-46. PubMed ID: 23189541
[TBL] [Abstract][Full Text] [Related]
18. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis.
Chorepsima S; Kechagias KS; Kalimeris G; Triarides NA; Falagas ME
Drug Des Devel Ther; 2018; 12():4059-4066. PubMed ID: 30568427
[TBL] [Abstract][Full Text] [Related]
19. Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis.
Alcaraz-Serrano V; Fernández-Barat L; Scioscia G; Llorens-Llacuna J; Gimeno-Santos E; Herrero-Cortina B; Vàzquez N; Puig de la Bellacasa J; Gabarrús A; Amaro-Rodriguez R; Menéndez R; Torres A
Respir Med; 2019; 154():40-46. PubMed ID: 31212120
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications.
Kwok WC; Ho JCM; Tam TCC; Ip MSM; Lam DCL
Respir Res; 2021 Apr; 22(1):132. PubMed ID: 33910573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
